Search
Roswell Park Oncology Year-In-Review: What Changed, What’s Next
… Oncology Prantesh Jain, MD, FACP Medical Oncology Emese Zsiros, MD, PhD, FACOG Gynecologic Oncology Saby George, MD, … Jain, MD 8:05-8:45 a.m. Gynecologic Oncology Emese Zsiros, MD 8:45-9:30 a.m. Head and Neck Cancer Aarti Bhatia, …
Research
Roswell Park-University of Chicago Ovarian Cancer SPORE Clinical Trials
… contact the Principal Investigator (Clinical), Emese Zsiros, MD, PhD, FACOG . Upcoming clinical trials A Phase … contact the Principal Investigator (Clinical), Emese Zsiros, MD, PhD, FACOG . Upcoming clinical trials A Phase …
Page with Layout
Faculty Mentors
… Sai Yendamuri, MD, MBA, FACS Thoracic Surgery Emese Zsiros, MD, PhD, FACOG Gynecologic Oncology Oncology …
Clinical Trial
NRG-GY032: A Phase II Study of Tailored Adjuvant Therapy in Pole-Mutated and p53-Wildtype/NSMP Early-Stage Endometrial Cancer (RAINBO BLUE & TAPER)
Blog Post
Does your gut biome affect your response to immunotherapy?
… The study was led by Principal Investigator Emese Zsiros, MD, PhD, FACOG , Chair of Gynecologic Oncology. All … the biological mechanisms behind them,” says Dr. Zsiros. “We observed that patients who experienced a … conditions. In the more immediate future, Drs. Zsiros and Rosario are exploring Dielma fastidiosa, a …
News
Roswell Park Community Comes Together to Celebrate Outstanding Physicians
Clinical Trial
Randomized Phase 2 Clinical Trial of Pembrolizumab Combined with Bevacizumab with or without Agonist Anti-CD40 CDX-1140 in Patients with Recurrent Ovarian Cancer
… CDX-1140 in Patients with Recurrent Ovarian Cancer II Zsiros, Emese This phase II trial tests whether pembrolizumab …
Department of Immunology Faculty
… Professor of Oncology Department of Immunology Emese Zsiros, MD, PhD, FACOG Professor of Oncology Co-Leader, Tumor …
Blog Post
Coping with hair loss: Jerrolynn's story
Clinical Trial